-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$2.00733.33% Upside
Vincerx Pharma, Inc. Frequently Asked Questions
-
What analysts cover Vincerx Pharma, Inc.?
Vincerx Pharma, Inc. has been rated by research analysts at Leerink Partners, Chardan Capital in the past 90 days.